Relationship between P-glycoprotein and second-generation antipsychotics

Author： Moons Tim   de Roo Mariska   Claes Stephan   Dom Geert  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.12, Iss.8, 2011-08, pp. : 1193-1211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Switching Between Second-Generation Antipsychotics: Why and How?

By Monika Edlinger   Susanne Baumgartner   Nadja Eltanaihi-Furtmüller   Martina Hummer   W. Wolfgang Fleischhacker  

CNS Drugs, Vol. 19, Iss. 1, 2005-01 ,pp. : 27-42

Adis International

Access to resources Recommend Favorite

Clinically relevant interactions between newer antidepressants and second-generation antipsychotics

By Spina Edoardo   de Leon Jose  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 5, 2014-05 ,pp. : 721-746

Informa Healthcare

Access to resources Recommend Favorite

Assessment of the First and Second Generation Antihistamines Brain Penetration and Role of P-Glycoprotein

By Obradovic Tanja   Dobson Glenn   Shingaki Tomotaka   Kungu Thomas   Hidalgo Ismael  

Pharmaceutical Research, Vol. 24, Iss. 2, 2007-02 ,pp. : 318-327

Springer Publishing Company

Access to resources Recommend Favorite

Second-generation antipsychotics associated with increased BMI

By  

Reactions Weekly, Vol. 1, Iss. 1191, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Second-generation antipsychotics associated with increased BMI

By  

Inpharma, Vol. 1, Iss. 1627, 2008-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite